NetraMark Holdings Inc AINMF

Primary Symbol: C.AIAI

Healthcare Medical Devices

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.

CSE:AIAI - Post by User

NetraMark Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by yopmemama021on Apr 13, 2022 5:14pm

301 Views

Post# 34601903

MEND

$MEND.c up 6.4% today following some big news for the company

$MEND is entering the oncology healthcare sphere in partnering with the Ontario Insititue for Cancer Research (OICR)

$MNNDF ’s AI will be used to leverage genome sequencing data surrounding pancreatic cancer, in hopes of identifying genetic biomarkers for the disease.Pancreatic cancer has a 5-year survival rate of just 10%

Very excited to see $MEND progressing healthcare in hopes of saving lives while and entering this domain( whose therapeutics market is worth USD $2.59 Billion)

https://www.newswire.ca/news-releases/nurosene-announces-research-partnership-in-oncology-with-the-ontario-institute-for-cancer-research-850422136.html

mc $20.14M

<< Previous

Bullboard Posts

Next >>

Vizsla uncovers record silver and gold grades in Mexico